KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$7.1 million.

  • Biogen's Tax Provisions fell 12862.9% to -$7.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $263.6 million, marking a year-over-year decrease of 372.53%. This contributed to the annual value of $263.6 million for FY2025, which is 372.53% down from last year.
  • As of Q4 2025, Biogen's Tax Provisions stood at -$7.1 million, which was down 12862.9% from $90.8 million recorded in Q3 2025.
  • Biogen's Tax Provisions' 5-year high stood at $443.2 million during Q4 2021, with a 5-year trough of -$409.1 million in Q2 2021.
  • For the 5-year period, Biogen's Tax Provisions averaged around $67.9 million, with its median value being $66.6 million (2024).
  • Within the past 5 years, the most significant YoY rise in Biogen's Tax Provisions was 323233.08% (2021), while the steepest drop was 19170.59% (2021).
  • Biogen's Tax Provisions (Quarter) stood at $443.2 million in 2021, then tumbled by 87.75% to $54.3 million in 2022, then fell by 21.36% to $42.7 million in 2023, then plummeted by 41.92% to $24.8 million in 2024, then plummeted by 128.63% to -$7.1 million in 2025.
  • Its Tax Provisions was -$7.1 million in Q4 2025, compared to $90.8 million in Q3 2025 and $109.2 million in Q2 2025.